Cancer News and Research

Latest Cancer News and Research

'Financial toxicity' of cancer treatment not adequately addressed by doctors, reveals study

In addition to facing new concerns about their health, individuals who are diagnosed with cancer often worry about the financial burdens of treatment.

23 Jul 2018

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.

23 Jul 2018

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

The U.S. Food and Drug Administration today approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation.

20 Jul 2018

Restoring mitochondrial function to reverse aging-related skin wrinkles, hair loss in mice

Wrinkled skin and hair loss are hallmarks of aging. What if they could be reversed?

20 Jul 2018

Exergaming can improve health in overweight and obese children, study shows

A new study from LSU's Pennington Biomedical Research Center showed for the first time that video games, in combination with fitness coaching and a step tracker, helped overweight children lose weight, lower their blood pressure and cholesterol and increase their physical activity.

20 Jul 2018

ECU researchers develop world’s first blood test that detects melanoma in its early stages

Edith Cowan University researchers have developed the world’s first blood test capable of detecting melanoma in its early stages, a breakthrough that will save thousands of lives, as well as millions of dollars for the health system.

20 Jul 2018

Researchers uncover cause for progression of prostate cancer to incurable stage

Researchers at the University of Oulu in Finland have discovered novel genes and mechanisms that can explain how a genomic variant in a single nucleotide polymorphism rs11672691 influences prostate cancer aggressiveness.

20 Jul 2018

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

A drug currently in clinical trials for treating symptoms of Parkinson's disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

20 Jul 2018

Study: Exposure to secondhand smoke increases the risk of stillbirth

Exposure to secondhand smoke is causing thousands of still births in developing countries, according to new research carried out by the University of York.

20 Jul 2018

Studies highlight issues regarding black lung, opioid overdose, police violence and more

This study found the national prevalence of coal worker's pneumoconiosis (black lung) is increasing among working coal miners. In central Appalachia, 20.6 percent of miners working more than 25 years have black lung disease.

20 Jul 2018

Researchers develop new way to uncover hidden breast cancer tumors

Breast cancer is the most common form of cancer among women, accounting for 25 % of all cancer cases worldwide.

20 Jul 2018

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

20 Jul 2018

Research: Dying at home could be beneficial for terminally ill cancer patients and their relatives

Dying at home could be beneficial for terminally ill cancer patients and their relatives, according to research published in the journal BMC Medicine.

20 Jul 2018

Child psychiatrist available on call to help assess separated immigrant children

Child psychiatrist Matthew Biel, MD, MSc, wasn't at all surprised to learn from news reports in early July that two children separated at the US border from their Central American parents and sent to Connecticut were diagnosed, by a Yale University psychiatrist, with "full blown acute post traumatic stress disorder."

20 Jul 2018

PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides

PureTech Health plc, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech's milk-derived exosome platform technology for the oral administration of Roche's antisense oligonucleotide platform.

20 Jul 2018

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine.

20 Jul 2018

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications

20 Jul 2018

Genetic sequencing reveals new clues to aggressiveness of prostate cancer

Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common.

20 Jul 2018

Top AI companies join hands to discover novel drugs for DMD

Insilico Medicine a leader in artificial intelligence for drug discovery, biomarker development and aging research, announced a research collaboration agreement with A2A Pharmaceuticals, Inc. A2A is a biotechnology company headquartered in New York and focused on development of novel drugs for unmet needs in oncology, drug resistant bacterial infections, and other life threatening diseases.

20 Jul 2018

ZHX2 protein could offer a new treatment strategy for kidney cancer

University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change.

20 Jul 2018

Cancer News and Research

Latest Cancer News and Research

'Financial toxicity' of cancer treatment not adequately addressed by doctors, reveals study

Pfizer announces FDA approval of biosimilar to Neupogen

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

Restoring mitochondrial function to reverse aging-related skin wrinkles, hair loss in mice

Exergaming can improve health in overweight and obese children, study shows

ECU researchers develop world’s first blood test that detects melanoma in its early stages

Researchers uncover cause for progression of prostate cancer to incurable stage

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

Study: Exposure to secondhand smoke increases the risk of stillbirth

Studies highlight issues regarding black lung, opioid overdose, police violence and more

Researchers develop new way to uncover hidden breast cancer tumors

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Research: Dying at home could be beneficial for terminally ill cancer patients and their relatives

Child psychiatrist available on call to help assess separated immigrant children

PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Genetic sequencing reveals new clues to aggressiveness of prostate cancer

Top AI companies join hands to discover novel drugs for DMD

ZHX2 protein could offer a new treatment strategy for kidney cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in